findmyKOL
Clinical trialNCT04311697CompletedPhase 2/PHASE3Interventional

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

SponsorAPR Applied Pharma Research s.a.Enrollment203Acute Lung InjuryAcute Respiratory Distress Syndrome (ARDS)Corona Virus InfectionCritical COVID-19 With Respiratory Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • St. Jude Medical Center

    Fullerton, California, United States

  • University of California - Irvine

    Irvine, California, United States

  • Baptist Hospital of Miami

    Miami, Florida, United States

  • Miller School of Medicine / University of Miami Medical Center

    Miami, Florida, United States

  • University of Louisville Hospital

    Louisville, Kentucky, United States

  • Heartland/mosaic Health

    Saint Joseph, Missouri, United States

  • Hendrick Health

    Abilene, Texas, United States

  • Texas Health Harris Methodist Hospital

    Fort Worth, Texas, United States

  • Texas Health Hospital Frisco

    Frisco, Texas, United States

  • Houston Methodist Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 May 2020
Primary completion
22 Feb 2021
Completion
22 Feb 2021
Last update posted
24 Jul 2023
Registered enrollment
203
Registry id
NCT04311697

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.